277 related articles for article (PubMed ID: 18688592)
1. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
[TBL] [Abstract][Full Text] [Related]
2. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
[TBL] [Abstract][Full Text] [Related]
3. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
4. Prognostic markers in renal cell carcinoma.
Ljungberg B
Curr Opin Urol; 2007 Sep; 17(5):303-8. PubMed ID: 17762621
[TBL] [Abstract][Full Text] [Related]
5. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
[TBL] [Abstract][Full Text] [Related]
6. Gene signatures of progression and metastasis in renal cell cancer.
Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
[TBL] [Abstract][Full Text] [Related]
8. Prognostic biomarkers in renal cell carcinoma.
Jiang Z
Expert Rev Mol Diagn; 2007 May; 7(3):293-307. PubMed ID: 17489736
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
10. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
Slabý O; Svoboda M; Michálek J; Vyzula R
Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
[TBL] [Abstract][Full Text] [Related]
11. [Cytokine-based and targeted therapy of metastatic renal cell carcinoma--a current analysis].
Johannsen M; Ringsdorf M; Römer A; Loening SA; Roigas J
Aktuelle Urol; 2007 Jan; 38(1):38-45. PubMed ID: 17290328
[TBL] [Abstract][Full Text] [Related]
12. [Transcriptome expression analyses of pulmonary renal cell carcinoma metastases].
Wuttig D; Höfling C; Füssel S; Meinhardt M; Herr A; Tennstedt P; Holotiuk O; Baretton G; Meye A; Grimm MO; Rolle A; Wirth MP
Urologe A; 2007 Sep; 46(9):1291-2. PubMed ID: 17619850
[No Abstract] [Full Text] [Related]
13. Molecular markers for predicting prognosis of renal cell carcinoma.
Nogueira M; Kim HL
Urol Oncol; 2008; 26(2):113-24. PubMed ID: 18312928
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of renal cell carcinoma and clinical implications.
Rogers CG; Tan MH; Teh BT
Urology; 2005 Feb; 65(2):231-7. PubMed ID: 15708028
[No Abstract] [Full Text] [Related]
15. Protein expression profiles in renal cell carcinoma: staging, prognosis, and patient selection for clinical trials.
Lam JS; Pantuck AJ; Belldegrun AS; Figlin RA
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):703s-708s. PubMed ID: 17255297
[TBL] [Abstract][Full Text] [Related]
16. Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival.
Sültmann H; von Heydebreck A; Huber W; Kuner R; Buness A; Vogt M; Gunawan B; Vingron M; Füzesí L; Poustka A
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):646-55. PubMed ID: 15701852
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
18. Reference genes for gene expression analysis by real-time reverse transcription polymerase chain reaction of renal cell carcinoma.
Bjerregaard H; Pedersen S; Kristensen SR; Marcussen N
Diagn Mol Pathol; 2011 Dec; 20(4):212-7. PubMed ID: 22089348
[TBL] [Abstract][Full Text] [Related]
19. [Introduction to the topic: molecular biological elucidation of renal cell carcinoma].
Küfer R; Hautmann R
Urologe A; 2006 Mar; 45(3):295-6. PubMed ID: 16482464
[No Abstract] [Full Text] [Related]
20. Molecular profiling of renal cancer: the journey to clinical application.
Ribal MJ
Eur Urol; 2011 May; 59(5):731-3. PubMed ID: 21296486
[No Abstract] [Full Text] [Related]
[Next] [New Search]
